The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.
India has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new instances of the infection.
The health ministry said that 5,22,149 deaths have been reported so far in the country.
A total 16,577 infections were reported in a day, while the death toll increased to 1,56,825 with 120 new fatalities, the data updated at 8 am showed.
The officials of Indian Council of Medical Research (ICMR) also said there are now 1,065 testing labs in the country -- 768 in the public sector and 297 in private.
This is the seventh consecutive day that COVID-19 cases have increased by more than 50,000.
While Maharashtra Home Minister Anil Deshmukh warned the yoga guru that the state government won't allow the sale of 'spurious' medicines, Rajasthan Health Minister Raghu Sharma also said that the state government will not allow the sale of Patanjali's Ayurvedic formulation.
The active cases further reduced to 30,27,925 comprising 11.63 per cent of the total infections, while the national COVID-19 recovery rate improved to 87.25 per cent.
The active cases have further reduced to 31,29,878, comprising 12.14 per cent of the total infections, while the national COVID-19 recovery rate has improved to 86.74 per cent, the data updated at 8 am showed.
According to the Indian Council of Medical Research, 20,79,77,229 samples have so far been tested for the viral disease in the country, including 6,44,931 on Tuesday.
The active cases comprise 0.03 per cent of the total infections, while the national COVID-19 recovery rate remained at 98.76 per cent, the ministry said.
The Vaccine War leans towards stoking nationalistic fervour, but that shouldn't stop you from watching a film that is solemn about the Indian scientific community's achievement, notes Mayur Sanap.
With this latest spike, the total cases in the country stand at 16,38,871.
A total of 74,91,513 people have recuperated from COVID-19 so far taking the national recovery rate to 91.54 per cent while the case fatality rate was recorded at 1.49 per cent.
The recovery rate among COVID-19 patients was recorded at 64.44 per cent, while the fatality rate was at 2.21 per cent.
Maharashtra Health Minister Rajesh Tope said the lowering of rates for the tests would provide a relief to the people.
The total coronavirus cases rose to 35,42,733, while the death toll climbed to 63,498 with 948 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
'...but subjecting our heritage to rigorous evidence-based understanding.'
Here is an explainer on the functioning of the seven-year-old body.
With 1,73,195 cases, Maharashtra has the highest number of active cases.
A reduction of 543 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
With 13,052 new coronavirus infections being reported in a day, India's COVID-19 tally has gone up to 1,07,46,183, while the number of people who have recuperated from the disease has surged to 1,04,23,125, according to the Union health ministry data updated on Sunday.
The active cases comprise 0.26 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.53 per cent, the ministry said.
The government on Friday said 25 cases of the Omicron variant of the coronavirus have been detected in India so far and that mostly mild symptoms have been noted in all the cases.
Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum Institute of India, report Shine Jacob and Sohini Das.
The death toll climbed to 5,25,242 with 19 new fatalities, the data updated at 8 am stated.
The active COVID-19 caseload of the country remained below two lakh for the fifth consecutive day.
The National Cancer Registry Programme was started by ICMR with a network of cancer registries across the country in December 1981.
This was the ninth day in a row that the COVID-19 tally increased by more than 50,000.
The active cases comprise 0.05 per cent of the total infections, while the national COVID-19 recovery rate has been recorded at 98.75 per cent, the ministry said.
The number of people who have recuperated from the disease surged to 1,01,29,111 pushing the national COVID-19 recovery rate to 96.51 per cent, while the COVID-19 case fatality rate stands at 1.44 per cent.
The preventive aspect of cancer is strengthened under comprehensive primary healthcare through the Ayushman Bharat Health and Wellness Centre scheme by the promotion of wellness activities and targeted communication at the community level.
"The homeopathy compound screened in vitro at NARI against HIV has been found to have a lot of potential in effectively killing the virus," Dr Ganguly told UNI. However, he refused to name the compound as there were Intellectual Property Rights issues involved. Moreover, there was a memorandum of understanding with the company which had given the compound, which is already being used in treatment of some other disease.
The death toll climbed to 5,24,974 with 20 more fatalities, the data updated at 8 am stated.
Registering a steady increase for the 36th day in a row, the active cases have increased to 14,71,877 comprising 10.46 per cent of the total infections.
After identifying the man who was the patient zero or index case of the Nipah virus outbreak in Kerala, the state government on Saturday began looking for the source and place from where he got infected by seeking details of his mobile tower locations.
Lack of sleep, unhealthy eating habits, physical inactivity and a stressful daily schedule stemming from demanding career paths to juggling multiple hats on the personal front are some factors that increase health challenges, especially in young Indians, notes dietician Sheryl Salis.
An increase of 2,613 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
A nasal vaccine, one expert said, is a "fantastic idea" for two reasons -- one, it can potentially create sterile immunity, and two, it is easy to administer and thus scalable.
